Head of Digestive OncologyDepartment of Gastroenterology/Digestive Oncology, University Hospitals Leuven and KU LeuvenLueven, Belgium
90: Pathological complete response to FLOT chemotherapy with or without durvalumab in resectable gastric and gastroesophageal junction cancer: subgroup analysis by region from the phase 3, randomized, double-blind MATTERHORN study
Friday, March 22, 202410:42am – 10:52am ET